Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$667,446,866
+$417,225,279 QoQ
Shares Held
556,470
+104.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
#116
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $1,321,975,737 across 10 Drug Manufacturers - General names. LLY ranks #1 (50.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
556,470 | $667,446,866 | |
| 2 | JNJ |
Johnson & Johnson
|
1,545,100 | $392,409,044 | |
| 3 | ABBV |
AbbVie Inc.
|
652,937 | $164,305,065 | |
| 4 | NVS |
Novartis AG
|
360,354 | $56,474,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
334,104 | $19,251,072 | |
| 6 | PFE |
Pfizer Inc
|
434,814 | $10,470,321 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,538 | $5,500,590 | |
| 8 | AMGN |
Amgen Inc
|
9,492 | $3,437,243 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,446,866 | 556,470 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $250,221,587 | 272,048 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $92,245,164 | 85,835 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $88,533,942 | 116,034 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $246,098,399 | 315,701 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $416,681,504 | 504,512 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $461,011,380 | 597,165 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $510,259,798 | 575,953 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $478,187,310 | 528,162 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $411,707,323 | 529,214 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $253,216,367 | 434,393 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $236,470,945 | 440,249 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $184,754,202 | 393,949 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,617,602 | 62,948 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,135,567 | 3,104 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||